COMPASS Pathways (CMPS) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

CMPS Stock Forecast


COMPASS Pathways stock forecast is as follows: an average price target of $23.00 (represents a 467.90% upside from CMPS’s last price of $4.05) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.

CMPS Price Target


The average price target for COMPASS Pathways (CMPS) is $23.00 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $23.00 to $23.00. This represents a potential 467.90% upside from CMPS's last price of $4.05.

CMPS Analyst Ratings


Buy

According to 5 Wall Street analysts, COMPASS Pathways's rating consensus is 'Buy'. The analyst rating breakdown for CMPS stock is 0 'Strong Buy' (0.00%), 5 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

COMPASS Pathways Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 22, 2024Leonid TimashevRBC Capital$23.00$7.43209.56%467.90%
Jun 05, 2024Vikram PurohitMorgan Stanley$23.00$6.70243.29%467.90%

The latest COMPASS Pathways stock forecast, released on Jul 22, 2024 by Leonid Timashev from RBC Capital, set a price target of $23.00, which represents a 209.56% increase from the stock price at the time of the forecast ($7.43), and a 467.90% increase from CMPS last price ($4.05).

COMPASS Pathways Price Target by Period


1M3M12M
# Anlaysts--2
Avg Price Target--$23.00
Last Closing Price$4.05$4.05$4.05
Upside/Downside-100.00%-100.00%467.90%

In the current month, the average price target of COMPASS Pathways stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to COMPASS Pathways's last price of $4.05. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Nov 11, 2024Canaccord GenuityBuyBuyHold
Nov 04, 2024H.C. WainwrightBuyBuyHold
Nov 01, 2024RBC CapitalOutperformOutperformHold
Jul 22, 2024RBC CapitalOutperformInitialise
Jun 05, 2024Morgan StanleyOverweightOverweightHold
Apr 01, 2024Morgan StanleyOverweightInitialise
Oct 13, 2022OppenheimerOutperformOutperformHold

COMPASS Pathways's last stock rating was published by Canaccord Genuity on Nov 11, 2024. The company gave CMPS a "Buy" rating, the same as its previous rate.

COMPASS Pathways Financial Forecast


COMPASS Pathways Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
Revenue-------
Avg Forecast-------
High Forecast-------
Low Forecast-------
# Analysts-------
Surprise %-------

COMPASS Pathways's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. CMPS's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

COMPASS Pathways EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts-------
EBITDA-------
Avg Forecast-------
High Forecast-------
Low Forecast-------
Surprise %-------

undefined analysts predict CMPS's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than COMPASS Pathways's previous annual EBITDA (undefined) of $NaN.

COMPASS Pathways Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts-------
Net Income-------
Avg Forecast$-32.68M$-33.11M$-37.09M$-38.21M$-42.82M$-39.00M$-36.83M
High Forecast$-32.68M$-33.11M$-37.09M$-37.47M$-38.74M$-39.00M$-36.83M
Low Forecast$-32.68M$-33.11M$-37.09M$-38.21M$-48.25M$-39.00M$-36.83M
Surprise %-------

COMPASS Pathways's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CMPS's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

COMPASS Pathways SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts-------
SG&A-------
Avg Forecast-------
High Forecast-------
Low Forecast-------
Surprise %-------

COMPASS Pathways's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to CMPS last annual SG&A of $NaN (undefined).

COMPASS Pathways EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts-------
EPS-------
Avg Forecast$-0.48$-0.48$-0.54$-0.56$-0.63$-0.57$-0.54
High Forecast$-0.48$-0.48$-0.54$-0.55$-0.57$-0.57$-0.54
Low Forecast$-0.48$-0.48$-0.54$-0.56$-0.71$-0.57$-0.54
Surprise %-------

According to undefined Wall Street analysts, COMPASS Pathways's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CMPS previous annual EPS of $NaN (undefined).

COMPASS Pathways Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
CMPSCOMPASS Pathways$4.20$23.00447.62%Buy
ACHCAcadia Healthcare Company$39.64$81.50105.60%Buy
AMEDAmedisys$85.37$143.3867.95%Hold
INNVInnovAge$4.08$6.8066.67%Hold
SGRYSurgery Partners$21.03$35.0066.43%Buy
AGLagilon health$2.00$3.1758.50%Buy
PNTGPennant Group$29.21$34.6718.69%Buy
CCRNCross Country Healthcare$17.90$21.0017.32%Buy
EHABEnhabit$8.29$9.5014.60%Hold
ENSGEnsign Group$140.00$159.0013.57%Buy
ADUSAddus HomeCare$130.73$146.2011.83%Buy
DVADaVita$147.57$145.00-1.74%Hold

CMPS Forecast FAQ


Is COMPASS Pathways a good buy?

Yes, according to 5 Wall Street analysts, COMPASS Pathways (CMPS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 100.00% of CMPS's total ratings.

What is CMPS's price target?

COMPASS Pathways (CMPS) average price target is $23 with a range of $23 to $23, implying a 467.90% from its last price of $4.05. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will COMPASS Pathways stock go up soon?

According to Wall Street analysts' prediction for CMPS stock, the company can go up by 467.90% (from the last price of $4.05 to the average price target of $23), up by 467.90% based on the highest stock price target, and up by 467.90% based on the lowest stock price target.

Can COMPASS Pathways stock reach $6?

CMPS's average twelve months analyst stock price target of $23 supports the claim that COMPASS Pathways can reach $6 in the near future.

What are COMPASS Pathways's analysts' financial forecasts?

COMPASS Pathways's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-119M (high $-115M, low $-124M), average SG&A $0 (high $0, low $0), and average EPS is $-1.735 (high $-1.675, low $-1.814). CMPS's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-141M (high $-140M, low $-141M), average SG&A $0 (high $0, low $0), and average EPS is $-2.063 (high $-2.052, low $-2.063).